Beersheba, Israel

Batella Benyaminovich

This inventor holds 1 USPTO granted patent. Top assignee: Sol-Gel Technologies Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Batella Benyaminovich. Retrieved from https://idiyas.com/inventor/batella-benyaminovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Batella Benyaminovich: Innovator in Pharmaceutical Compositions

Introduction

Batella Benyaminovich is a notable inventor based in Beer-Sheva, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of topical vaginal formulations. His innovative work focuses on enhancing the efficacy and comfort of these compositions.

Latest Patents

Batella holds a patent for "Pharmaceutical compositions comprising silica microspheres." This patent details topical vaginal compositions that include silica microspheres and an active ingredient, such as estradiol, metronidazole, clindamycin, or butoconazole, in amounts ranging from 0.001 to 15.0% w/w. The compositions are designed to provide sustained release of the active ingredient, thereby reducing skin irritation and improving patient comfort.

Career Highlights

Batella is associated with Sol-Gel Technologies Ltd., where he applies his expertise in pharmaceutical development. His work at the company has been instrumental in advancing innovative solutions in the healthcare sector.

Collaborations

He collaborates with talented individuals such as Marina Shevachman and Amira Ze' Evi, contributing to a dynamic team focused on research and development in pharmaceutical technologies.

Conclusion

Batella Benyaminovich's contributions to pharmaceutical compositions exemplify the impact of innovation in healthcare. His work not only enhances the effectiveness of treatments but also prioritizes patient comfort and safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…